{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:55:08Z","timestamp":1787061308827,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.pathol.2023.02.007","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T10:57:18Z","timestamp":1681901838000},"page":"650-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Increased STAT expression in Reed\u2013Sternberg cells as a potential positive prognostication biomarker in Hodgkin lymphoma"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8911-3113","authenticated-orcid":false,"given":"Ahmad","family":"Zargari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine D.","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hosking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-8326","authenticated-orcid":false,"given":"Stephen B.","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2023.02.007_bib1","series-title":"SEER Cancer Statistics Review","author":"Howlader","year":"2021"},{"key":"10.1016\/j.pathol.2023.02.007_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1470-2045(13)70341-3","article-title":"Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis","volume":"14","author":"Skoetz","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pathol.2023.02.007_bib3","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A\u00a0prognostic score for advanced Hodgkin's disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2023.02.007_bib4","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2023.02.007_bib5","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2023.02.007_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2023.02.007_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood.2019000568","article-title":"An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma","volume":"134","author":"Murray","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2023.02.007_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13045-021-01214-y","article-title":"STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer","volume":"14","author":"Awasthi","year":"2021","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.pathol.2023.02.007_bib9","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1158\/1078-0432.CCR-13-3007","article-title":"Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in\u00a0vitro and in\u00a0vivo","volume":"20","author":"Hao","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2023.02.007_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008525","article-title":"Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection","volume":"16","author":"Jung","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.pathol.2023.02.007_bib11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2023.02.007_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1634\/theoncologist.2018-0058","article-title":"Comprehensive genomic profiling of Hodgkin lymphoma reveals recurrently mutated genes and increased mutation burden","volume":"24","author":"Liang","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.pathol.2023.02.007_bib13","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2023.02.007_bib14","first-page":"2914","article-title":"Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens","volume":"54","author":"Dowell","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2023.02.007_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920917558","article-title":"Predicting STAT1 as a prognostic marker in patients with solid cancer","volume":"12","author":"Zhang","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.pathol.2023.02.007_bib16","article-title":"Prognostic role of phospho-STAT3 in patients with cancers of the digestive system: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2023.02.007_bib17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3109\/10428194.2013.824079","article-title":"CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma","volume":"55","author":"Kayal","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2023.02.007_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/path.2744","article-title":"The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas","volume":"222","author":"K\u00f6bel","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2023.02.007_bib19","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1080\/10428190600667721","article-title":"Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin's lymphoma","volume":"47","author":"Feuerborn","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2023.02.007_bib20","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1016\/S2352-3026(16)30108-9","article-title":"The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study","volume":"3","author":"Agostinelli","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.pathol.2023.02.007_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/421821","article-title":"Role of STAT3 in cancer metastasis and translational advances","volume":"2013","author":"Kamran","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.pathol.2023.02.007_bib22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2023.02.007_bib23","doi-asserted-by":"crossref","first-page":"32244","DOI":"10.1074\/jbc.M005082200","article-title":"Dimer stability as a determinant of differential DNA binding activity of Stat3 isoforms","volume":"275","author":"Park","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2023.02.007_bib24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1158\/1078-0432.CCR-15-1253","article-title":"The opposing function of STAT3 as an oncoprotein and tumor suppressor is dictated by the expression status of STAT3\u03b2 in esophageal squamous cell carcinoma","volume":"22","author":"Zhang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2023.02.007_bib25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biocel.2019.02.006","article-title":"STAT3beta, a distinct isoform from STAT3","volume":"110","author":"Zhang","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pathol.2023.02.007_bib26","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1158\/1078-0432.CCR-09-2658","article-title":"Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis","volume":"16","author":"Pectasides","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2023.02.007_bib27","first-page":"594","article-title":"Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis","volume":"9","author":"Dolled-Filhart","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2023.02.007_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601003","article-title":"Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis","volume":"89","author":"Hsiao","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2023.02.007_bib29","first-page":"19","article-title":"STAT1 in cancer: friend or foe?","volume":"24","author":"Zhang","year":"2017","journal-title":"Discov Med"},{"key":"10.1016\/j.pathol.2023.02.007_bib30","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/leu.2009.103","article-title":"STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line","volume":"23","author":"Baus","year":"2009","journal-title":"Leukemia"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523001101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523001101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:29:55Z","timestamp":1758472195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302523001101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0031302523001101"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2023.02.007","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased STAT expression in Reed\u2013Sternberg cells as a potential positive prognostication biomarker in Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2023.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}